Europe In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

Publication Month: May 2021 | Report Code: TIPRE00022122 | No. of Pages: 211 | Category: Medical Device | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The In-vitro diagnostics market in Europe is expected to grow from US$ 15,973.0 million in 2019 to US$ 22,221.8 million by 2027; it is estimated to grow at a CAGR of 4.2% from 2020 to 2027.

The region is witnessing exponential increase in prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Certain factors, such as poor sanitary conditions, lack of public hygiene, massive air pollution, and lack of safe drinking water, are playing a significant role in the increasing prevalence of infectious diseases. For instance, according to data published by the World Health Organization (WHO) in 2019, approximately 71.0 million people suffered from hepatitis C virus infection across the globe. Moreover, extreme globalization, intense mobility of the population, and persistent urbanization are expected to spread viral infections with greater ease. Since there is a lack of better public health surveillance systems and access to care, a substantial population in developing countries as well as remote regions, is highly prone to viral infections. This, combined with considerable growth in the viral epidemics, is projected to offer a high demand the in-vitro diagnostics (IVD) during the forecast period

 

The coronavirus pandemic has offered unprecedented growth opportunities and challenges for the European region's in-vitro diagnostic market. The in-vitro diagnostics market has experienced profitable growth due to the raised awareness and increased demand for in-vitro diagnostics tests. The IVD product manufacturers primarily supported the growth of the market. The manufacturers were at the frontline and have invested in the expertise, production, distribution of the IVD products. On the other hand, there are several regulatory challenges concerning IVD. The regulatory bodies are involved in the development of new in vitro Diagnostic Regulation (IVDR). It is expected that the IVDR will be fully implemented from May 26, 2022. According to the new regulations, manufacturers will have to re-certify all tests on time and the infrastructure facilities. In contrast, there have been significant installations of PCR and qPCR in the laboratories and hospitals to improve the capacity of COVID-19 tests. Countries such as Italy, Spain, and the UK have faced a significant number of patients. Therefore, these countries have significantly contributed to the growth of the in-vitro diagnostics market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the In-vitro diagnostics market. The Europe In-vitro diagnostics market is expected to grow at a good CAGR during the forecast period.

Get more information on this report :

Europe In-Vitro Diagnostics Market Segmentation          

By Product and Services

  • Instruments
  • Reagents & Kits
  • Software & Services

By Technology

  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation & Hemostasis
  • Hematology
  • Urinalysis
  • Others

By Application

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Others

By End User

  • Hospitals
  • Laboratories
  • Homecare
  • Others

By Country

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe

 

Companies Mentioned

  • F. HOFFMANN-LA ROCHE LTD.
  • DANAHER
  • ABBOTT
  • SIEMENS AG
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • BD
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN

 

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          In-Vitro Diagnostics Market – By Product and Services

1.3.2          In-Vitro Diagnostics Market – By Technology

1.3.3          In-Vitro Diagnostics Market – By Application

1.3.4          In-Vitro Diagnostics Market – By End User

1.3.5          Europe In-Vitro Diagnostics Market – By Country

2.           Europe In-Vitro Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Europe In-Vitro Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          In-Vitro Diagnostics Market- Europe PEST Analysis

4.3          Expert Opinion

5.           Europe In-Vitro Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increasing Prevalence of Chronic and Infectious Diseases

5.1.2          Growing Geriatric Population

5.1.3          Rising Demand for In-Vitro Diagnostics During COVID-19 Pandemic

5.2          Market Restraints

5.2.1          Lack of Healthcare Infrastructure and Reimbursement Policies

5.3          Future Trends

5.3.1          Increasing Adoption and Popularity of Automation in Clinical Laboratories

5.4          Impact Analysis

6.           In-Vitro Diagnostics Market – Europe Analysis

6.1          Europe In-Vitro Diagnostics Market Revenue Forecasts and Analysis

7.           Europe In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Product and Services

7.1          Overview

7.2          In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

7.3          Reagents & Kits

7.3.1          Overview

7.3.2          Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

7.4          Instruments

7.4.1          Overview

7.4.2          Instruments Market Revenue and Forecast to 2027 (US$ Mn)

7.5          Software & Services

7.5.1          Overview

7.5.2          Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

8.           Europe In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Technology

8.1          Overview

8.2          In-Vitro Diagnostics Market, by Technology, 2019 & 2027 (% Share)

8.3          Immunoassay/Immunochemistry

8.3.1          Overview

8.3.2          Immunoassay/Immunochemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.4          Clinical Chemistry

8.4.1          Overview

8.4.2          Clinical Chemistry Market Revenue and Forecast to 2027 (US$ Mn)

8.5          Molecular Diagnostics

8.5.1          Overview

8.5.2          Molecular Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

8.6          Microbiology

8.6.1          Overview

8.6.2          Microbiology Market Revenue and Forecast to 2027 (US$ Mn)

8.7          Blood Glucose Self-Monitoring

8.7.1          Overview

8.7.2          Blood Glucose Self-Monitoring Market Revenue and Forecast to 2027 (US$ Mn)

8.8          Coagulation and Hemostasis

8.8.1          Overview

8.8.2          Coagulation and Hemostasis Market Revenue and Forecast to 2027 (US$ Mn)

8.9          Haematology

8.9.1          Overview

8.9.2          Haematology Market Revenue and Forecast to 2027 (US$ Mn)

8.10        Urinalysis

8.10.1        Overview

8.10.2        Urinalysis Market Revenue and Forecast to 2027 (US$ Mn)

8.11        Others

8.11.1        Overview

8.11.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

9.           Europe In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Application

9.1          Overview

9.2          In-Vitro Diagnostics Market, by Application, 2019 & 2027 (% Share)

9.3          Infectious Diseases

9.3.1          Overview

9.3.2          Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)

9.4          Diabetes

9.4.1          Overview

9.4.2          Diabetes Market Revenue and Forecast to 2027 (US$ Mn)

9.5          Oncology

9.5.1          Overview

9.5.2          Oncology Market Revenue and Forecast to 2027 (US$ Mn)

9.6          Cardiology

9.6.1          Overview

9.6.2          Cardiology Market Revenue and Forecast to 2027 (US$ Mn)

9.7          Autoimmune Disease

9.7.1          Overview

9.7.2          Autoimmune Disease Market Revenue and Forecast to 2027 (US$ Mn)

9.8          Nephrology

9.8.1          Overview

9.8.2          Nephrology Market Revenue and Forecast to 2027 (US$ Mn)

9.9          Others

9.9.1          Overview

9.9.2          Others Market Revenue and Forecast to 2027 (US$ Mn)

10.        Europe In-Vitro Diagnostics Market Analysis and Forecasts to 2027– By End user

10.1        Overview

10.2        In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

10.3        Hospitals

10.3.1        Overview

10.3.2        Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

10.4        Laboratories

10.4.1        Overview

10.4.2        Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

10.5        Homecare

10.5.1        Overview

10.5.2        Homecare Market Revenue and Forecast to 2027 (US$ Mn)

10.6        Others

10.6.1        Overview

10.6.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

11.        In-Vitro Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis

11.1        Europe In-Vitro Diagnostics Market Revenue and Forecast to 2027

11.1.1        Europe In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

11.1.2        UK

11.1.2.1          UK In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.2.1.1           UK In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.2.1.2           UK In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.2.1.3           UK In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.2.1.4           UK In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.3        Germany

11.1.3.1          Germany In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.3.1.1           Germany In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.3.1.2           Germany In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.3.1.3           Germany In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.3.1.4           Germany In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.4        France

11.1.4.1          France In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.4.1.1           France In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.4.1.2           France In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.4.1.3           France In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.4.1.4           France In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.6        Italy

11.1.6.1          Italy In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.6.1.1           Italy In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.6.1.2           Italy In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.6.1.3           Italy In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.6.1.4           Italy In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.7        Spain

11.1.7.1          Spain In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.7.1.1           Spain In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)

11.1.7.1.2           Spain In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.7.1.3           Spain In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.7.1.4           Spain In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

11.1.8        Rest of Europe

11.1.8.1          Rest of Europe In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)

11.1.8.1.1           Rest of Europe In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product and Services (US$ Mn)

11.1.8.1.2           Rest of Europe In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)

11.1.8.1.3           Rest of Europe In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)

11.1.8.1.4           Rest of Europe In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)

12.        Impact Of COVID-19 Pandemic on Europe In-Vitro Diagnostics Market

12.1        Europe: Impact Assessment of COVID-19 Pandemic

13.        Industry Landscape

13.1        Overview

13.2        Organic Developments Done by The Companies in The Market

13.3        Inorganic Developments Done by The Companies in The Market

14.        COMPANY PROFILES

14.1        Abbott

14.1.1        Key Facts

14.1.2        Business Description

14.1.3        Products and Services

14.1.4        Financial Overview

14.1.5        SWOT Analysis

14.1.6        Key Developments

14.2        F. HOFFMANN-LA ROCHE LTD.

14.2.1        Key Facts

14.2.2        Business Description

14.2.3        Products and Services

14.2.4        Financial Overview

14.2.5        SWOT Analysis

14.2.6        Key Developments

14.3        Danaher

14.3.1        Key Facts

14.3.2        Business Description

14.3.3        Products and Services

14.3.4        Financial Overview

14.3.5        SWOT Analysis

14.3.6        Key Developments

14.4        Siemens AG

14.4.1        Key Facts

14.4.2        Business Description

14.4.3        Products and Services

14.4.4        Financial Overview

14.4.5        SWOT Analysis

14.4.6        Key Developments

14.5        Sysmex Corporation

14.5.1        Key Facts

14.5.2        Business Description

14.5.3        Products and Services

14.5.4        Financial Overview

14.5.5        SWOT Analysis

14.5.6        Key Developments

14.6        THERMO FISHER SCIENTIFIC INC.

14.6.1        Key Facts

14.6.2        Business Description

14.6.3        Products and Services

14.6.4        Financial Overview

14.6.5        SWOT Analysis

14.6.6        Key Developments

14.7        BD

14.7.1        Key Facts

14.7.2        Business Description

14.7.3        Products and Services

14.7.4        Financial Overview

14.7.5        SWOT Analysis

14.7.6        Key Developments

14.8        bioMerieux SA

14.8.1        Key Facts

14.8.2        Business Description

14.8.3        Products and Services

14.8.4        Financial Overview

14.8.5        SWOT Analysis

14.8.6        Key Developments

14.9        BIO-RAD LABORATORIES INC.

14.9.1        Key Facts

14.9.2        Business Description

14.9.3        Products and Services

14.9.4        Financial Overview

14.9.5        SWOT Analysis

14.9.6        Key Developments

14.10     QIAGEN

14.10.1      Key Facts

14.10.2      Business Description

14.10.3      Products and Services

14.10.4      Financial Overview

14.10.5      SWOT Analysis

14.10.6      Key Developments

15.        Appendix

15.1        About the Insight Partners

15.2        Glossary of Terms


 

LIST OF TABLES

Table 1.              Key launches 2016: By Roche

Table 2.              UK In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 3.              UK In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 4.              UK In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 5.              UK In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 6.              Germany In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 7.              Germany In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 8.              Germany In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 9.              Germany In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 10.            France In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 11.            France In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 12.            France In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 13.            France In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 14.            Italy In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 15.            Italy In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 16.            Italy In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 17.            Italy In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 18.            Spain In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)

Table 19.            Spain In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 20.            Spain In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 21.            Spain In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 22.            Rest of Europe In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product and Services (US$ Mn)

Table 23.            Rest of Europe In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)

Table 24.            Rest of Europe In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)

Table 25.            Rest of Europe In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 26.            Organic Developments Done by The Companies

Table 27.            Inorganic Developments Done by The Companies

Table 28.            Glossary of Terms, In-Vitro Diagnostics Market

 

LIST OF FIGURES

Figure 1.            In-Vitro Diagnostics Market Segmentation

Figure 2.            Europe In-Vitro Diagnostics Market Overview

Figure 3.            Reagents and Kits Segment Held Largest Share of Product and Services in In-Vitro Diagnostics Market

Figure 4.            Infectious Diseases Segment Held Largest Share of Application in In-Vitro Diagnostics Market

Figure 5.            UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.            In-Vitro Diagnostics Market - Europe PEST Analysis

Figure 7.            In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints

Figure 8.            Europe In-Vitro Diagnostics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.            In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)

Figure 10.          Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)

Figure 11.          Instruments Market Revenue and Forecast to 2027 (US$ Mn)

Figure 12.          Software & Services Market Revenue and Forecast to 2027 (US$ Mn)

Figure 13.          In-Vitro Diagnostics Market, By Technology, 2019 & 2027 (% Share)

Figure 14.          Immunoassay/Immunochemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 15.          Clinical Chemistry Market Revenue And Forecast To 2027 (US$ Mn)

Figure 16.          Molecular Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 17.          Microbiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 18.          Blood Glucose Self-Monitoring Market Revenue And Forecast To 2027 (US$ Mn)

Figure 19.          Coagulation and Hemostasis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 20.          Hematology Market Revenue and Forecast to 2027 (US$ Mn)

Figure 21.          Urinalysis Market Revenue And Forecast To 2027 (US$ Mn)

Figure 22.          Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 23.          In-Vitro Diagnostics Market, By Application, 2019 & 2027 (% Share)

Figure 24.          Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)

Figure 25.          Diabetes Market Revenue And Forecast To 2027 (US$ Mn)

Figure 26.          Most Prevalent Forms of Cancers Globally, 2018

Figure 27.          Oncology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 28.          Cardiology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 29.          Autoimmune Disease Market Revenue And Forecast To 2027 (US$ Mn)

Figure 30.          Nephrology Market Revenue And Forecast To 2027 (US$ Mn)

Figure 31.          Others Market Revenue And Forecast To 2027 (US$ Mn)

Figure 32.          In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)

Figure 33.          Hospitals Market Revenue And Forecast To 2027 (US$ Mn)

Figure 34.          Laboratories Market Revenue And Forecast To 2027 (US$ Mn)

Figure 35.          Homecare Market Revenue And Forecast To 2027 (US$ Mn)

Figure 36.          Others Market Revenue and Forecast to 2027 (US$ Mn)

Figure 37.          Europe In-Vitro Diagnostics Market Revenue, By Country, 2019 (US$ Mn)

Figure 38.          Europe In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)

Figure 39.          UK In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 40.          Germany In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 41.          France In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 42.          Italy In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 43.          Spain In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 44.          Rest of Europe In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)

Figure 45.          Impact of COVID-19 Pandemic in European Country Markets

Figure 46.          Growth Strategies Done by the Companies in the Market, (%)

 

 

  1. F. HOFFMANN-LA ROCHE LTD.
  2. DANAHER
  3. ABBOTT
  4. SIEMENS AG
  5. SYSMEX CORPORATION
  6. THERMO FISHER SCIENTIFIC, INC.
  7. BD
  8. BIOMERIEUX SA
  9. BIO-RAD LABORATORIES, INC.
  10. QIAGEN
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe In-vitro diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe In-vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the in-vitro diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00022122
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing